ATE335741T1 - 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren - Google Patents

8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren

Info

Publication number
ATE335741T1
ATE335741T1 AT03732655T AT03732655T ATE335741T1 AT E335741 T1 ATE335741 T1 AT E335741T1 AT 03732655 T AT03732655 T AT 03732655T AT 03732655 T AT03732655 T AT 03732655T AT E335741 T1 ATE335741 T1 AT E335741T1
Authority
AT
Austria
Prior art keywords
pyridine derivatives
ligands
fluorimidazo
gaba receptors
sub
Prior art date
Application number
AT03732655T
Other languages
English (en)
Inventor
Wesley Peter Blackaby
Pineiro Jose Luis Castro
Simon Charles Goodacre
David James Hallett
Alexander Charles Humphries
Philip Jones
Kevin John Merchant
Michael Reader
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE335741T1 publication Critical patent/ATE335741T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT03732655T 2002-05-24 2003-05-23 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren ATE335741T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0212049.1A GB0212049D0 (en) 2002-05-24 2002-05-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE335741T1 true ATE335741T1 (de) 2006-09-15

Family

ID=9937397

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03732655T ATE335741T1 (de) 2002-05-24 2003-05-23 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren

Country Status (10)

Country Link
US (1) US7226926B2 (de)
EP (1) EP1511748B1 (de)
JP (1) JP2005535598A (de)
AT (1) ATE335741T1 (de)
AU (1) AU2003239687B2 (de)
CA (1) CA2486753A1 (de)
DE (1) DE60307462T2 (de)
ES (1) ES2270044T3 (de)
GB (1) GB0212049D0 (de)
WO (1) WO2003099817A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514563B2 (en) * 2005-06-09 2009-04-07 Board Of Trustees Of Michigan State University Process for producing cyano substituted arene boranes and compounds
US7425556B2 (en) 2005-12-20 2008-09-16 Astrazeneca Ab Compounds and uses thereof
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
HRP20150642T1 (hr) 2006-12-22 2015-08-14 Astex Therapeutics Limited BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a
US8513276B2 (en) 2006-12-22 2013-08-20 Astex Therapeutics Limited Imidazo[1,2-a]pyridine compounds for use in treating cancer
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
WO2010009166A1 (en) 2008-07-14 2010-01-21 Gilead Colorado, Inc. Oxindolyl inhibitor compounds
CA2729909A1 (en) 2008-07-14 2010-01-21 Gilead Sciences, Inc. Imidazolyl pyrimidine inhibitor compounds
US8124764B2 (en) 2008-07-14 2012-02-28 Gilead Sciences, Inc. Fused heterocyclyc inhibitor compounds
CN102123987A (zh) 2008-07-28 2011-07-13 吉里德科学公司 亚环烷基和亚杂环烷基组蛋白脱乙酰酶抑制剂化合物
JP2012521354A (ja) 2009-03-20 2012-09-13 アムジエン・インコーポレーテツド Pi3キナーゼの阻害薬
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US8283357B2 (en) 2009-06-08 2012-10-09 Gilead Sciences, Inc. Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
KR20120031170A (ko) 2009-06-08 2012-03-30 길리애드 사이언시즈, 인코포레이티드 알카노일아미노 벤즈아미드 아닐린 hdac 저해제 화합물
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
BR112020015396A2 (pt) * 2018-01-29 2020-12-08 Merck Patent Gmbh Inididores de gcn2 e usos dos mesmos
JP7229257B2 (ja) 2018-01-29 2023-02-28 メルク パテント ゲーエムベーハー Gcn2阻害剤およびその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927687D0 (en) * 1999-11-23 2000-01-19 Merck Sharp & Dohme Therapeutic agents
EP1294723A1 (de) * 2000-05-24 2003-03-26 MERCK SHARP & DOHME LTD. 3-phenyl-imidazo-pyrimidin derivate als liganden für gaba rezeptoren
ATE338758T1 (de) 2001-03-23 2006-09-15 Merck Sharp & Dohme Imidazopyrimidin-derivate als liganden für gaba- rezeptoren
WO2003076442A1 (en) * 2002-03-05 2003-09-18 Eli Lilly And Company Purine derivatives as kinase inhibitors
GB0212048D0 (en) * 2002-05-24 2002-07-03 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
AU2003239687B2 (en) 2009-01-29
JP2005535598A (ja) 2005-11-24
GB0212049D0 (en) 2002-07-03
DE60307462D1 (de) 2006-09-21
DE60307462T2 (de) 2007-08-02
EP1511748A1 (de) 2005-03-09
ES2270044T3 (es) 2007-04-01
WO2003099817A1 (en) 2003-12-04
CA2486753A1 (en) 2003-12-04
US7226926B2 (en) 2007-06-05
US20060052385A1 (en) 2006-03-09
EP1511748B1 (de) 2006-08-09
AU2003239687A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
ATE335741T1 (de) 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren
DE60214532D1 (de) Imidazopyrimidin-derivate als liganden für gaba-rezeptoren
DE60304572D1 (de) Imidazopyridin derivate als liganden für gaba rezeptoren
ATE270672T1 (de) Imidazopyridinderivate als liganden für gaba- rezeptoren
ATE310002T1 (de) Imidazotriazin-derivate als gaba-rezeptor- liganden
DE60115282D1 (de) Imidazotriazin-derivate als liganden für gaba-rezeptoren
BG108166A (en) Imidazo-pyrimidine derivatives as liigands for gaba receptors
ATE255109T1 (de) Imidazopyridinderivate als gaba rezeptor liganden
DE60325865D1 (de) Phenylpyridazin derivative als liganden für gaba-rezeptoren
DE60312701T8 (de) Darstellung von 1h-imidazo[4,5-c]chinolin-4-aminen über neue 1h-imidazo[4,5-c] chinolin-4-cyano- und 1h-imidazo[4,5-c]chinolin-4-carboxamid intermediate
ATE253066T1 (de) Imidazotriazinderivate als gaba rezeptor-liganden
PL334084A1 (en) Methods of obtaining 9,11-epoxysteroides and their useful intermediate compounds
ATE250062T1 (de) Triazolopiridazinederivate als gaba rezeptor- liganden
EP1566384A4 (de) Neue azolderivate
Sugimori et al. Synthesis and antitumor activity of ring A-and F-modified hexacyclic camptothecin analogues
ATE249457T1 (de) Indolderivate und ihre verwendung als serotoninrezeptor-liganden
WO2004055026A8 (en) Tetracyclic 3-substituted indoles having serotonin receptor affinity
Mekouar et al. New pyridone approach: total synthesis of mappicine ketone (nothapodytine B)
TW200609218A (en) Bicyclic compounds
ATE359269T1 (de) 4-arylsulphonylpiperidin-derivate als 5-ht2a - rezeptor antagonisten
DE602005011177D1 (de) Pyridinketone mit herbizideffekt
Halimehjani et al. Investigation of the Reaction of In Situ Prepared Dithiocarbamic Acids with Itaconic Anhydride in Water
PE44299A1 (es) Derivados sustituidos de triazolo-piridacina como ligandos para receptores gaba

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties